The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 25, 2026

Filed:

Mar. 17, 2022
Applicant:

Schrödinger, Inc., New York, NY (US);

Inventors:

Sayan Mondal, La Jolla, CA (US);

Haifeng Tang, Metuchen, NJ (US);

Xianhai Huang, Warren, NJ (US);

Adam Marc Levinson, Bronx, NY (US);

Leah Frye, Portland, OR (US);

Sathesh Bhat, New York, NY (US);

Pieter Harm Bos, New York, NY (US);

Zef Konst, San Francisco, CA (US);

Phani Ghanakota, Edison, NJ (US);

Jeremy Robert Greenwood, Brooklyn, NY (US);

Assignee:

SCHRÖDINGER, INC., New York, NY (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 495/04 (2006.01); A61K 31/4365 (2006.01); A61K 31/4375 (2006.01); A61K 31/4743 (2006.01); A61K 31/5377 (2006.01); C07D 495/14 (2006.01);
U.S. Cl.
CPC ...
C07D 495/04 (2013.01); A61K 31/4365 (2013.01); A61K 31/4375 (2013.01); A61K 31/4743 (2013.01); A61K 31/5377 (2013.01); C07D 495/14 (2013.01);
Abstract

The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof. The present application also describes pharmaceutical composition comprising a compound of Formula (I), and pharmaceutically acceptable salts thereof, and methods of using the compounds and compositions for inhibiting kinase activity, and for treating cancer.


Find Patent Forward Citations

Loading…